# AEON Biopharma, Inc.: Form 10-Q/A for the period ended Mar 31, 2025

- Company: [AEON Biopharma, Inc.](/companies/aeon.md) (CIK 1837607)
- Form: 10-Q/A
- Filed: 2025-06-11
- Accepted by EDGAR: Jun 11, 2025, 16:06 ET
- Period: 2025-03-31
- Accession: 0001104659-25-058535
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1837607/000110465925058535/tm2517714d1_10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1837607/000110465925058535/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1837607/000110465925058535/tm2517714d1_10qa.htm

Filed Jun 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-058535. Last ingested by Listed: Nov 3, 2026, 09:04 ET. No prices; not investment advice.